A Win For Mesoblast Limited
Tue, Mar 26, 2024 at 07:19 PM
Mesoblast Limited (MESO:NASDAQ) rocketted at $3.93, representing a gain of 78.6%. On Tue, Mar 26, 2024, MESO:NASDAQ hit a New 2-Week High of $3.93. The stock appeared on our News Catalysts scanner on Tue, Mar 26, 2024 at 06:11 PM in the 'BIOTECH' category. From Tue, Mar 12, 2024, the stock recorded 30.00% Up Days and 45.45% Green Days
About Mesoblast Limited (MESO:NASDAQ)
Mesoblast Ltd is engaged in the development of biologic products for the broad field of regenerative medicine. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage adult stem cells.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 111.11%
- Mesoblast Limited (MESO:NASDAQ), 78.64%
- Cazoo Group Ltd Class A (CZOO:NYSE), 61.08%
- Stoke Therapeutics, Inc. (STOK:NASDAQ), 58.31%
- OpGen, Inc. (OPGN:NASDAQ), 57.86%
- Concord Medical Services Holdings Limited (CCM:NYSE), 47.66%
- Krispy Kreme Inc. (DNUT:NASDAQ), 39.36%
- C3is Inc. (CISS:NASDAQ), 36.65%
- AirNet Technology Inc. (ANTE:NASDAQ), 34.15%
- Puyi Inc. (PUYI:NASDAQ), 33.93%